Anthrax vaccine

US7638333B2 · kind B2 · utility

Assignee

• The United States of America as represented by the Secretary of the Army · US

Inventors

• John S. Lee · Hagerstown, US
• Peter Pushko · Frederick, US
• Michael Parker · Frederick, US
• Jonathan F. Smith · Cary, US
• Susan L. Welkos · Frederick, US

Key dates

• Filing date: May 21, 2003
• Grant date: Dec 29, 2009
• Expiry date: Feb 23, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/021
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Using the nontoxic PA protein from B. anthracis, a method and composition for use in inducing an immune response which is protective against anthrax in subjects is described.